Are peptides legal in Brazil?
Sourced guide to the legal status of peptides in Brazil, refreshed automatically from live research.
Overall Status: Restricted
Short answer: Peptides are restricted in Brazil: only a handful of specific peptides (such as insulin, semaglutide, tirzepatida, and recombinant human growth hormone/somatropin) are ANVISA-registered medicines available strictly by prescription, while research or "research chemical" peptides like BPC-157 and TB-500 have no ANVISA registration in any category and are illegal to sell or use for human health purposes, including cosmetic use.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides are restricted in Brazil, with the national health regulator ANVISA drawing a sharp line between a small number of registered, prescription-only medicines and the large, growing market of unregistered "research" peptides. ANVISA has publicly stated that many injectable peptides marketed online are illegal because they lack registration as a medicine, food, cosmetic, or supplement in Brazil. Growth-hormone-related and anabolic peptides fall under Brazil's controlled-substances list (Portaria 344/98), the Federal Council of Medicine (CFM) has banned prescribing anabolic/androgenic hormone therapies for aesthetic or performance purposes, and ANVISA has taken recent enforcement actions restricting compounding of GLP-1 peptides and beauty-hormone implants.
Key Points
- ANVISA has publicly warned that injectable peptides sold online for aesthetic or physical-performance purposes are illegal in Brazil because they are not authorized for use as supplements and are not registered in any product category. [3]
- Only semaglutide, tirzepatida, and recombinant human growth hormone have ANVISA registration among the widely-discussed peptide class, meaning peptides like BPC-157, TB-500, GHK-Cu, retatrutide, Semax, Selank, tesamorelina, CJC-1295, and ipamorelina are not registered for injectable human use in Brazil. [1]
- Personal importation of unregistered research peptides such as BPC-157 into Brazil is not legally permitted for individuals, because Brazil's personal-import allowance generally requires the product to have approval in its country of origin, which BPC-157 lacks from the FDA, EMA, or ANVISA. [7]
- Brazil's Receita Federal (customs authority) allows personal import of unregistered medicines for individual, non-commercial use only if they do not contain substances subject to special control under Portaria 344/98, and require a medical prescription to prove personal use. [10]
- Somatropina (human growth hormone) is classified on List C5 (anabolic substances) of Brazil's Portaria SVS/MS 344/1998, requiring a special-control prescription (Receita de Controle Especial) with a 30-day validity and quantity limits for dispensing. [9]
- ANVISA prohibited compounding pharmacies from manipulating semaglutide in August 2025, ruling that its active pharmaceutical ingredient can only be imported by manufacturers holding the registered product's approval in Brazil, while continuing to permit compounded tirzepatida under stricter quality controls. [4]
- Brazil's Federal Council of Medicine (CFM), through Resolution 2.333/2023, prohibits physicians from prescribing androgenic/anabolic hormone therapies (a category that includes growth hormone and related peptide-adjacent substances) for aesthetic, muscle-gain, or athletic-performance purposes. [12]
- In October 2024 ANVISA suspended the manipulation, sale, advertising, and use of compounded hormonal implants known as "chips da beleza," and after revision in November 2024 kept the ban specifically on implants containing anabolic steroids or androgenic hormones for aesthetic or performance purposes. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Brazil
| BPC-157 | BPC-157 is not approved or registered by ANVISA in Brazil in any category (medicine, food, cosmetic, or supplement), making its sale and injectable use illegal, and it cannot be legally personally imported because it lacks approval from ANVISA, the FDA, or the EMA. [2] |
|---|
| Semaglutide / GLP-1 (weight-loss and diabetes) | Semaglutide is legal in Brazil only as an ANVISA-registered biotechnological medicine (e.g., Ozempic, Wegovy) obtained by prescription, and since August 2025 ANVISA has barred compounding pharmacies from manipulating semaglutide because its active ingredient may only be imported by the manufacturer holding the registered product's approval. [4] |
|---|
| Tirzepatide (Mounjaro, GLP-1 class) | Tirzepatide is legal in Brazil both as the ANVISA-registered medicine Mounjaro and, under Nota Técnica 92/2024, as a compounded formulation prepared under strict quality-control rules because it is a synthetically-derived active ingredient rather than a biotechnological one like semaglutide. [6] |
|---|
| TB-500 | TB-500 has no ANVISA registration and is not considered an approved medicine in Brazil, so its commercialization and human use are treated as illegal and restricted to laboratory research purposes only. [11] |
|---|
| Human Growth Hormone (HGH/somatropin) | Recombinant somatropin is a legal, ANVISA-registered prescription medicine in Brazil for diagnosed growth hormone deficiency, but it is listed as a controlled anabolic substance (List C5 of Portaria 344/98) and cannot be lawfully prescribed for anti-aging, aesthetic, or athletic performance purposes under CFM Resolution 2.333/2023. [9] |
|---|
Last researched: 2026-09-10
Frequently asked questions
No, you cannot legally buy BPC-157 or similar unregistered research peptides in Brazil under any circumstances, with or without a prescription, because ANVISA has not registered these substances in any product category and considers them illegal for human use, including cosmetic use.
[13]
Generally no for unregistered research peptides: Brazil's personal-import rule requires the product to be approved in its country of origin and not contain substances under special control, and a casual postal shipment of unregistered research peptides does not reliably meet the personal-use exemption and can be seized by Receita Federal.
[7]
Registered peptide medicines such as semaglutide, tirzepatida, and somatropin can be prescribed by a licensed Brazilian physician within approved indications or documented off-label use, but the Federal Council of Medicine (CFM) prohibits any physician, including via telehealth, from prescribing anabolic/androgenic hormone therapies for aesthetic or athletic-performance purposes.
[8]
Unregistered or controlled peptide shipments seized by Receita Federal or flagged by ANVISA are typically retained or destroyed as illegal imports, and compounding pharmacies caught manipulating unauthorized peptide active ingredients (like non-compliant semaglutide or beauty-implant hormones) can face fines, facility interdiction, and loss of authorization under ANVISA's enforcement actions.
[5]
No, using somatropin (HGH) for anti-aging, aesthetic, or muscle-building purposes is not a lawful medical indication in Brazil; it is only ANVISA-approved and prescribable for diagnosed growth hormone deficiency or related endocrine conditions, and CFM rules bar physicians from prescribing such hormone therapies for aesthetic or performance goals.
[12]